Citation: M. Satterfield et al., Detection of the isoflavone aglycones genistein and daidzein in urine using solid-phase microextraction-high-performance liquid chromatography-electrospray ionization mass spectrometry, J CHROMAT B, 759(1), 2001, pp. 33-41
Authors:
Tobias, ES
Hurlstone, AFL
MacKenzie, E
McFarlane, R
Black, DM
Citation: Es. Tobias et al., The TES gene at 7q31,1 is methylated in tumours and encodes a novel growth-suppressing LIM domain protein, ONCOGENE, 20(22), 2001, pp. 2844-2853
Authors:
Chrischilles, EA
Dasbach, EJ
Rubenstein, LM
Cook, JR
Tabor, HK
Black, DM
Citation: Ea. Chrischilles et al., The effect of alendronate on fracture-related healthcare utilization and costs: The fracture intervention trial, OSTEOPOR IN, 12(8), 2001, pp. 654-660
Authors:
Tosteson, ANA
Jonsson, B
Grima, DT
O'Brien, BJ
Black, DM
Adachi, JD
Citation: Ana. Tosteson et al., Challenges for model-based economic evaluations of postmenopausal osteoporosis interventions, OSTEOPOR IN, 12(10), 2001, pp. 849-857
Authors:
Black, DM
Thompson, DE
Bauer, DC
Ensrud, K
Musliner, T
Hochberg, MC
Nevitt, MC
Suryawanshi, S
Cummings, SR
Citation: Dm. Black et al., Fracture risk reduction with alendronate in women with osteoporosis: The Fracture Intervention Trial (vol 85, pg 4118, 2000), J CLIN END, 86(2), 2001, pp. 938-938
Authors:
Pedro-Botet, J
Schaefer, EJ
Bakker-Arkema, RG
Black, DM
Stein, EM
Corella, D
Ordovas, JM
Citation: J. Pedro-botet et al., Apolipoprotein E genotype affects plasma lipid response to atorvastatin ina gender specific manner, ATHEROSCLER, 158(1), 2001, pp. 183-193
Authors:
Cauley, JA
Black, DM
Barrett-Connor, E
Harris, F
Shields, K
Applegate, W
Cummings, SR
Citation: Ja. Cauley et al., Effects of hormone replacement therapy on clinical fractures and height loss: The heart and estrogen/progestin replacement study (HERS), AM J MED, 110(6), 2001, pp. 442-450
Authors:
McKenney, JM
McCormick, LS
Schaefer, EJ
Black, DM
Watkins, ML
Citation: Jm. Mckenney et al., Effect of niacin and atorvastatin on lipoprotein subclasses in patients with atherogenic dyslipidemia, AM J CARD, 88(3), 2001, pp. 270-274
Authors:
Salamone, LM
Cauley, JA
Zmuda, J
Pasagian-Macaulay, A
Epstein, RS
Ferrell, RE
Black, DM
Kuller, LH
Citation: Lm. Salamone et al., Apolipoprotein E gene polymorphism and bone loss: Estrogen status modifiesthe influence of apolipoprotein E on bone loss, J BONE MIN, 15(2), 2000, pp. 308-314
Authors:
Black, DM
Thompson, DE
Bauer, DC
Ensrud, K
Musliner, T
Hochberg, MC
Nevitt, MC
Suryawanshi, S
Cummings, SR
Citation: Dm. Black et al., Fracture risk reduction with alendronate in women with osteoporosis: The Fracture Intervention Trial, J CLIN END, 85(11), 2000, pp. 4118-4124
Authors:
Raal, FJ
Pappu, AS
Illingworth, DR
Pilcher, GJ
Marais, AD
Firth, JC
Kotze, MJ
Heinonen, TM
Black, DM
Citation: Fj. Raal et al., Inhibition of cholesterol synthesis by atorvastatin in homozygous familialhypercholesterolaemia, ATHEROSCLER, 150(2), 2000, pp. 421-428
Citation: Rg. Bakker-arkema et al., Safety profile of atrovastatin-treated patients with low LDL-cholesterol levels, ATHEROSCLER, 149(1), 2000, pp. 123-129
Authors:
Liede, A
Cohen, B
Black, DM
Davidson, RH
Renwick, A
Hoodfar, E
Olopade, OI
Micek, M
Anderson, V
De Mey, R
Fordyce, A
Warner, E
Dann, JL
King, MC
Weber, B
Narod, SA
Steel, CM
Citation: A. Liede et al., Evidence of a founder BRCA1 mutation in Scotland, BR J CANC, 82(3), 2000, pp. 705-711
Authors:
Nevitt, MC
Thompson, DE
Black, DM
Rubin, SR
Ensrud, K
Yates, AJ
Cummings, SR
Citation: Mc. Nevitt et al., Effect of alendronate on limited-activity days and bed-disability days caused by back pain in postmenopausal women with existing vertebral fractures, ARCH IN MED, 160(1), 2000, pp. 77-85
Authors:
Isaacsohn, JL
Davidson, MH
Hunninghake, D
Singer, R
McLain, R
Black, DM
Citation: Jl. Isaacsohn et al., Aggressive lipid-lowering initiation abates new cardiac events (ALLIANCE) - Rationale and design of atorvastatin versus usual care in hypercholesterolemic patients with coronary artery disease, AM J CARD, 86(2), 2000, pp. 250-252
Authors:
Dujovne, CA
Harris, WS
Altman, R
Overhiser, RW
Black, DM
Citation: Ca. Dujovne et al., Effect of Atorvastatin on hemorheologic-hemostatic parameters and serum fibrinogen levels in hyperlipidemic patients, AM J CARD, 85(3), 2000, pp. 350-353
Authors:
Buist, DSM
LaCroix, AZ
Black, DM
Harris, F
Blank, J
Ensrud, K
Edgerton, D
Rubin, S
Fox, KM
Citation: Dsm. Buist et al., Inclusion of older women in randomized clinical trials: Factors associatedwith taking study medication in the fracture intervention trial, J AM GER SO, 48(9), 2000, pp. 1126-1131
Authors:
Ensrud, KE
Thompson, DE
Cauley, JA
Nevitt, MC
Kado, DM
Hochberg, MC
Santora, AC
Black, DM
Citation: Ke. Ensrud et al., Prevalent vertebral deformities predict mortality and hospitalization in older women with low bone mass, J AM GER SO, 48(3), 2000, pp. 241-249